﻿<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xml:lang="en-US">
  <channel>
    <title>Latest articles from Medical Marketing and Media Podcasts</title>
    <link>http://feeds.feedburner.com/mmmpodcasts</link>
    <description>Latest articles from Medical Marketing and Media Podcasts</description>
    <itunes:author><![CDATA[MM&M]]></itunes:author>
    <itunes:subtitle>Podcasts</itunes:subtitle>
    <itunes:summary><![CDATA[]]></itunes:summary>
    <itunes:owner>
      <itunes:name>Podcasts</itunes:name>
      <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
    </itunes:owner>
    <itunes:category text="Business">
      <itunes:category text="Business News" />
    </itunes:category>
    <itunes:image href="https://media.mmm-online.com/images/2017/01/03/mmmnewlogowebtest_1124719.jpg"></itunes:image>
    <itunes:explicit>no</itunes:explicit>
    <atom:link href="http://feeds.feedburner.com/mmmpodcasts" rel="self" type="application/rss+xml" />
    <item>
      <title>Podcast: Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients</title>
      <description>In this sponsored podcast, MM&amp;M's Larry Dobrow speaks with Robert Leedom, senior analytics consultant at TrialCard, and Paul LeVine, VP of analytic services for TrialCard, about how to reach patients by leveraging brand data.</description>
      <link>https://www.mmm-online.com/podcast-adherence-leveraging-data-to-enhance-your-brands-ability-to-reach-target-patients/article/522636/</link>
      <pubDate>Wed, 14 Sep 2016 18:25:19 GMT</pubDate>
      <itunes:summary>In this sponsored podcast, MM&amp;M's Larry Dobrow speaks with Robert Leedom, senior analytics consultant at TrialCard, and Paul LeVine, VP of analytic services for TrialCard, about how to reach patients by leveraging brand data.</itunes:summary>
      <itunes:author><![CDATA[MM&M]]></itunes:author>
      <guid>https://www.mmm-online.com/podcast-adherence-leveraging-data-to-enhance-your-brands-ability-to-reach-target-patients/article/522636/</guid>
    </item>
    <item>
      <title>Podcast: No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers</title>
      <description>Marc Iskowitz, MM&amp;M's editor in chief, discusses a qualitative/quantitative approach to meeting orphan drug marketers' engagement challenge with Michael Carlin, VP at TrialCard, in this sponsored podcast.</description>
      <link>https://www.mmm-online.com/podcast-no-patient-left-behind-connecting-rare-disease-patients-to-orphan-drug-manufacturers/article/512302/</link>
      <pubDate>Wed, 27 Jul 2016 20:42:11 GMT</pubDate>
      <itunes:summary>Marc Iskowitz, MM&amp;M's editor in chief, discusses a qualitative/quantitative approach to meeting orphan drug marketers' engagement challenge with Michael Carlin, VP at TrialCard, in this sponsored podcast.</itunes:summary>
      <itunes:author><![CDATA[MM&M]]></itunes:author>
      <guid>https://www.mmm-online.com/podcast-no-patient-left-behind-connecting-rare-disease-patients-to-orphan-drug-manufacturers/article/512302/</guid>
    </item>
    <item>
      <title>Podcast: "I Need to Transition My HUB Program. What Do I Do Next?" Here are Best Practices for a Successful HUB Program Transition</title>
      <description>In this sponsored podcast, Marc Iskowitz, MM&amp;M's editor in chief, discusses best practices for successfully transitioning HUB programs with Scott Dulitz, VP of market access solutions at TrialCard.</description>
      <link>https://www.mmm-online.com/podcast-i-need-to-transition-my-hub-program-what-do-i-do-next-here-are-best-practices-for-a-successful-hub-program-transition/article/501243/</link>
      <pubDate>Mon, 06 Jun 2016 20:35:31 GMT</pubDate>
      <itunes:summary>In this sponsored podcast, Marc Iskowitz, MM&amp;M's editor in chief, discusses best practices for successfully transitioning HUB programs with Scott Dulitz, VP of market access solutions at TrialCard.</itunes:summary>
      <itunes:author><![CDATA[MM&M]]></itunes:author>
      <guid>https://www.mmm-online.com/podcast-i-need-to-transition-my-hub-program-what-do-i-do-next-here-are-best-practices-for-a-successful-hub-program-transition/article/501243/</guid>
    </item>
    <item>
      <title>Podcast: What Does Success Look Like in Patient Affordability?</title>
      <description>Larry Dobrow, senior editor of MM&amp;M, discusses what success in patient affordability looks like with Paul LeVine, VP of analytic services for TrialCard, in this sponsored podcast.</description>
      <link>https://www.mmm-online.com/podcast-what-does-success-look-like-in-patient-affordability/article/486128/</link>
      <pubDate>Tue, 29 Mar 2016 19:05:18 GMT</pubDate>
      <itunes:summary>Larry Dobrow, senior editor of MM&amp;M, discusses what success in patient affordability looks like with Paul LeVine, VP of analytic services for TrialCard, in this sponsored podcast.</itunes:summary>
      <itunes:author><![CDATA[MM&M]]></itunes:author>
      <guid>https://www.mmm-online.com/podcast-what-does-success-look-like-in-patient-affordability/article/486128/</guid>
    </item>
    <item>
      <title>Podcast: AstraZeneca's "Take it from a fish"</title>
      <description>MM&amp;M's Jaimy Lee talks with Sudler &amp; Hennessey's Rob Rogers, 2015 Lions Health pharma jury president, about what this campaign has to with the ongoing debate about creativity versus conservatism in pharma advertising.</description>
      <link>https://www.mmm-online.com/podcast-astrazenecas-take-it-from-a-fish/article/450694/</link>
      <pubDate>Fri, 30 Oct 2015 19:50:41 GMT</pubDate>
      <itunes:summary>MM&amp;M's Jaimy Lee talks with Sudler &amp; Hennessey's Rob Rogers, 2015 Lions Health pharma jury president, about what this campaign has to with the ongoing debate about creativity versus conservatism in pharma advertising.</itunes:summary>
      <itunes:author><![CDATA[MM&M]]></itunes:author>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp3/https://media.mmm-online.com/audios/170/final_final_podcast_oct_mm_m_42375.mp3" type="audio/mpeg" />
      <guid>https://www.mmm-online.com/podcast-astrazenecas-take-it-from-a-fish/article/450694/</guid>
    </item>
    <item>
      <title>Podcast: Pfizer's and Bristol-Myers Squibb's "Cardiac Resuscitation" </title>
      <description>MM&amp;M's Larry Dobrow talks to Michael Maher, president of ID Health, about the advertising for Eliquis. The DTC campaign launched last year.</description>
      <link>https://www.mmm-online.com/podcast-pfizers-and-bristol-myers-squibbs-cardiac-resuscitation/article/434371/</link>
      <pubDate>Mon, 24 Aug 2015 16:18:02 GMT</pubDate>
      <itunes:summary>MM&amp;M's Larry Dobrow talks to Michael Maher, president of ID Health, about the advertising for Eliquis. The DTC campaign launched last year.</itunes:summary>
      <itunes:author><![CDATA[MM&M]]></itunes:author>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp3/https://media.mmm-online.com/audios/145/campaign_checkup_-_ep_1_36101.mp3" type="audio/mpeg" />
      <guid>https://www.mmm-online.com/podcast-pfizers-and-bristol-myers-squibbs-cardiac-resuscitation/article/434371/</guid>
    </item>
  </channel>
</rss>